Search
19/06/2024
Diagnostic accuracy of serum calprotectin measured by CLIA and EIA in juvenile idiopathic arthritis: a proof-of-concept study
Codes-Méndez, H, Magallares-López, B, Park, HS, Mariscal, A, Juárez, C, Boronat, S, Martínez-Martínez, L, Corominas, H. Diagnostic accuracy of serum calprotectin measured by CLIA and EIA in juvenile idiopathic arthritis: a proof-of-concept study. Frontiers in Pediatrics. 2024; 12DOI:10.3389/fped.2024.1422916. PMID:38962573. IF:2.000(Q2/4D).
19/06/2024
Therapeutic implications for sphingolipid metabolism in metabolic dysfunction-associated steatohepatitis
Ramos-Molina, B, Rossell, J, de Oca, APM, Pardina, E, Genua, I, Rojo-Lopez, MI, Julian, MT, Alonso, N, Julve, J, Mauricio, D. Therapeutic implications for sphingolipid metabolism in metabolic dysfunction-associated steatohepatitis. Frontiers in Endocrinology. 2024; 15DOI:10.3389/fendo.2024.1400961. PMID:38962680. IF:4.600(Q1/3D).
19/06/2024
Diabetic foot disease carries an intrinsic high risk of mortality and other severe outcomes in type 2 diabetes: a propensity score-matched retrospective population-based study
Vlacho, B, Bundó, M, Llussà, J, Real, J, Mata-Cases, M, Cos, X, Tundidor, D, Zaccardi, F, Khunti, K, Jude, EB, Franch-Nadal, J, Mauricio, D. Diabetic foot disease carries an intrinsic high risk of mortality and other severe outcomes in type 2 diabetes: a propensity score-matched retrospective population-based study. Cardiovascular Diabetology. 2024; 23(1)DOI:10.1186/s12933-024-02303-1. PMID:38898525. IF:10.600(Q1/1D).
19/06/2024
Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy
Pinana, JL, Vazquez, L, Heras, I, Aiello, TF, López-Corral, L, Arroyo, I, Soler-Espejo, E, García-Cadenas, I, Garcia-Gutierrez, V, Aroca, C, Chorao, P, Olave, MT, Lopez-Jimenez, J, Gómez, MA, Arellano, E, Cuesta-Casas, M, Avendano-Pita, A, González-Santillana, C, Hernández-Rivas, JA, Roldán-Perez, A, Mico-Cerdá, M, Guerreiro, M, Morell, J, Rodriguez-Galvez, P, Labrador, J, Campos, D, Cedillo, A, Vidal, CG, Martino, R, Solano, C. Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy. Frontiers in Oncology. 2024; 14DOI:10.3389/fonc.2024.1389345. PMID:39015498. IF:3.300(Q2/4D).
18/06/2024
The Five Periampullary Cancers, not Just Different Siblings but Different Families: An International Multicenter Cohort Study
Uijterwijk, BA, Lemmers, DH, Ghidini, M, Wilmink, H, Zaniboni, A, Salvia, R, Fusai, GK, Koerkamp, BG, Koek, S, Ghorbani, P, Zerbi, A, Nappo, G, Luyer, M, Goh, BKP, Roberts, KJ, Boggi, U, Mavroeidis, VK, White, S, Kazemier, G, Björnsson, B, Serradilla-Martín, M, House, MG, Alseidi, A, Ielpo, B, Mazzola, M, Jamieson, N, Wellner, U, Soonawalla, Z, Cabús, SS, Dalla Valle, R, Pessaux, P, Vladimirov, M, Kent, TS, Tang, CN, Fisher, WE, Kleeff, J, Mazzotta, A, Muñoz, MAS, Berger, AC, Ball, CG, Korkolis, D, Bannone, E, Ferarri, C, Besselink, MG, Abu Hilal, M. The Five Periampullary Cancers, not Just Different Siblings but Different Families: An International Multicenter Cohort Study. ANNALS OF SURGICAL ONCOLOGY. 2024; 31(9)DOI:10.1245/s10434-024-15555-8. PMID:38888860. IF:3.500(Q1/2D).
18/06/2024
Hybrid Micro-/Nanoprotein Platform Provides Endocrine-like and Extracellular Matrix-like Cell Delivery of Growth Factors
López-Laguna, H, Tsimbouri, PM, Jayawarna, V, Rigou, I, Serna, N, Voltà-Durán, E, Unzueta, U, Salmeron-Sanchez, M, Vázquez, E, Dalby, MJ, Villaverde, A. Hybrid Micro-/Nanoprotein Platform Provides Endocrine-like and Extracellular Matrix-like Cell Delivery of Growth Factors. ACS Applied Materials & Interfaces. 2024; 16(26)DOI:10.1021/acsami.4c01210. PMID:38888932. IF:8.200(Q1/2D).